Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
series B
Biotech
BMS-backed TORL grabs $158M to march army of ADCs through clinic
For companies exploring the antibody-drug conjugate arena, the interest from Big Pharma and big-pocketed investors appears to be as strong as ever.
James Waldron
Apr 10, 2024 9:35am
Neuropsych biotech Engrail closes $157M series B
Mar 19, 2024 8:00am
Tubulis rides wave of ADC interest to $138M financing round
Mar 14, 2024 9:12am
Sionna adds $182M to extend pipeline, cash runway through 2026
Mar 6, 2024 8:00am
Capitalizing on ADC frenzy, ProfoundBio attracts $112M series B
Feb 13, 2024 7:00am
Ambience Healthcare reels in $70M for generative AI tools
Feb 7, 2024 10:18am